Jennifer Kamocsay - 24 Sep 2026 Form 3 Insider Report for CARLSMED, INC. (CARL)

Reporting relationship: Chief Legal Officer
Issuer ticker: CARL
Reported as of: 24 Sep 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 30 Sep 2026, 19:51:20 UTC
Prior SEC filing: 10 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Jennifer Kamocsay

Key filing fact

Jennifer Kamocsay filed Form 3 for CARLSMED, INC. (CARL) on 30 Sep 2026.

Key facts

This page summarizes Jennifer Kamocsay's Form 3 filing for CARLSMED, INC. (CARL).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 30 Sep 2026, 19:51.

Change

Previous filing in this sequence was filed on 10 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001967264 Primary reporting owner

Kamocsay Jennifer

Relationship: Chief Legal Officer
Address: C/O CARLSMED, INC., 1800 ASTON AVE, SUITE 100, CARLSBAD
Signature: /s/ Jennifer Kamocsay
Signature date: 30 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CARL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 56,222
Date: 24 Sep 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CARL holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 24 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $13.45
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date, January 28, 2026, subject to the Reporting Person's continued service through each such vesting date.

Footnote F2

Includes 90,000 vested and unvested stock options convertible into approximately 90,000 shares of the Issuer's Common Stock. 25% of the stock options vested upon the one year anniversary of the grant date, September 29, 2025, and the remaining 75% of the stock options will vest in 1/12th installments on a quarterly basis thereafter, subject to the Reporting Person's continued service through each such vesting date.